CT-0991
/ Zhejiang University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 25, 2025
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=24 | Suspended | Sponsor: He Huang | Recruiting ➔ Suspended
Trial suspension • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
November 19, 2025
A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: MEI HENG
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
1 to 2
Of
2
Go to page
1